NEXT - Dallas — Dallas, Texas

NEXT - Dallas is a clinical research site located in Dallas, Texas, United States 75039.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

NEXT - Dallas has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Adenocarcinoma.

Sponsors: Revolution Medicines, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT - Dallas?

NEXT - Dallas has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT - Dallas conducted?

NEXT - Dallas has 1 clinical trials on record, with 1 currently active. Their work covers Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Pancreatic Adenocarcinoma.

Is NEXT - Dallas accredited by Crixeo Health?

NEXT - Dallas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NEXT - Dallas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.